https://old.international-pharma.com/fda-authorizes-pfizer-biontech-covid-19-vaccine-for-emergency-use-in-adolescents-in-another-important-action-in-fight-against-pandemic/ 2023-10-19T22:52:37+00:00 https://old.international-pharma.com/us-approves-pfizer-covid-19-vaccine-for-children-aged-12-to-15/ 2023-10-19T22:52:36+00:00 https://old.international-pharma.com/mhra-approves-label-extension-for-vertexs-kaftrio-combo/ 2023-10-19T22:52:35+00:00 https://old.international-pharma.com/novavax-announces-positive-preclinical-data-for-combination-influenza-and-covid-19-vaccine-candidate/ 2023-10-19T22:52:35+00:00 https://old.international-pharma.com/phico-therapeutics-raises-7m-to-advance-next-gen-antibiotic-candidate/ 2023-10-19T22:52:31+00:00 https://old.international-pharma.com/cphi-discover-in-the-future-pharma-companies-will-need-to-work-closer-with-excipient-companies-if-we-are-to-develop-better-formulations-and-faster/ 2023-10-19T22:52:30+00:00 https://old.international-pharma.com/wp-content/uploads/2021/05/Iain-Moore-scaled-1.jpg https://old.international-pharma.com/medicago-and-gsks-plant-derived-covid-19-vaccine-achieves-positive-trial-results/ 2023-10-19T22:52:29+00:00 https://old.international-pharma.com/sanofi-and-gsk-covid-19-vaccine-candidate-demonstrates-positive-phase-ii-results/ 2023-10-19T22:52:29+00:00 https://old.international-pharma.com/novo-nordisks-ziltivekimab-hits-primary-endpoint-in-ckd-trial/ 2023-10-19T22:52:28+00:00 https://old.international-pharma.com/merck-extends-oncology-and-autoimmunity-collaboration-with-biomed-x/ 2023-10-19T22:52:27+00:00 https://old.international-pharma.com/pandemic-coincided-with-increase-in-mental-health-problems-for-children/ 2023-10-19T22:52:27+00:00 https://old.international-pharma.com/experts-state-contract-services-sector-the-big-winner-of-pandemic-at-cphi-discover/ 2023-10-19T22:52:26+00:00 https://old.international-pharma.com/60-million-doses-of-covid-19-vaccine-administered-in-uk/ 2023-10-19T22:52:25+00:00 https://old.international-pharma.com/nice-guidance-gives-patients-with-rare-blood-disorders-access-to-new-treatment/ 2023-10-19T22:52:25+00:00 https://old.international-pharma.com/opdivo-plus-yervoy-moves-closer-to-eu-approval-for-dmmr-msi-h-colorectal-cancer/ 2023-10-19T22:52:21+00:00 https://old.international-pharma.com/takedas-dengue-vaccine-bags-positive-long-term-efficacy-results/ 2023-10-19T22:52:20+00:00 https://old.international-pharma.com/ec-approves-ponvory-for-relapsing-ms/ 2023-10-19T22:52:19+00:00 https://old.international-pharma.com/biotech-ab/ 2023-10-19T22:52:19+00:00 https://old.international-pharma.com/wp-content/uploads/2021/05/Picture1.jpg https://old.international-pharma.com/wp-content/uploads/2021/05/Picture2.png https://old.international-pharma.com/acg-makes-two-significant-european-appointments/ 2023-10-19T22:52:18+00:00 https://old.international-pharma.com/wp-content/uploads/2021/05/Bild-4.png https://old.international-pharma.com/wp-content/uploads/2021/05/007.jpg https://old.international-pharma.com/who-validates-sinovac-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations/ 2023-10-19T22:52:17+00:00 https://old.international-pharma.com/fda-approves-alkermes-lybalvi-for-schizophrenia-and-bipolar-i-disorder/ 2023-10-19T22:52:17+00:00 https://old.international-pharma.com/janssens-myeloma-car-t-therapy-cilta-cel-demonstrates-sustained-efficacy/ 2023-10-19T22:52:16+00:00 https://old.international-pharma.com/cosentyx-approved-to-treat-plaque-psoriasis-in-paediatric-patients/ 2023-10-19T22:52:15+00:00 https://old.international-pharma.com/amgen-and-kyowa-kirin-agree-to-jointly-develop-eczema-med/ 2023-10-19T22:52:14+00:00 https://old.international-pharma.com/bsp-pharmaceuticals-continues-expansions-and-investments-in-latinas-plant/ 2023-10-19T22:52:10+00:00 https://old.international-pharma.com/wp-content/uploads/2021/06/Newsletter-text.jpg https://old.international-pharma.com/cdc-covid-19-study-shows-mrna-vaccines-reduce-risk-of-infection-by-91-percent-for-fully-vaccinated-people/ 2023-10-19T22:52:10+00:00 https://old.international-pharma.com/bayer-to-advance-two-first-of-its-kind-cell-and-gene-therapies-for-parkinsons-disease/ 2023-10-19T22:52:09+00:00 https://old.international-pharma.com/momentous-moment-as-fda-approves-aducanumab-as-treatment-for-alzheimers-disease/ 2023-10-19T22:52:08+00:00 https://old.international-pharma.com/new-research-identifies-single-biomarker-that-can-indicate-underlying-neurodegeneration/ 2023-10-19T22:52:08+00:00 https://old.international-pharma.com/nice-recommends-tecentriq-for-first-line-nsclc/ 2023-10-19T22:52:07+00:00 https://old.international-pharma.com/aptar-pharma-names-nordic-semiconductor-key-supplier-for-digital-healthcare-solutions-portfolio/ 2023-10-19T22:52:06+00:00 https://old.international-pharma.com/wp-content/uploads/2021/06/Aptar.jpg https://old.international-pharma.com/novavaxs-covid-19-vaccine-shows-90-efficacy-in-phase-iii/ 2023-10-19T22:52:06+00:00 https://old.international-pharma.com/az-pfizer-biontech-vaccines-highly-effective-against-delta-variant/ 2023-10-19T22:52:05+00:00 https://old.international-pharma.com/imbruvica-venclyxto-tops-gazyva-plus-chemo-in-first-line-cll-sll/ 2023-10-19T22:52:04+00:00 https://old.international-pharma.com/biogens-inherited-eye-disease-gene-therapy-misses-the-mark-in-late-stage-trial/ 2023-10-19T22:52:01+00:00 https://old.international-pharma.com/opdivo-plus-yervoy-scores-nice-backing-for-certain-bowel-cancer-patients/ 2023-10-19T22:52:00+00:00 https://old.international-pharma.com/fda-approves-bayers-astepro-for-otc-use-in-us/ 2023-10-19T22:51:59+00:00 https://old.international-pharma.com/nemera-breaks-ground-in-brazil-through-milfra-acquisition/ 2023-10-19T22:51:59+00:00 https://old.international-pharma.com/wp-content/uploads/2021/06/milfra-logo-002.png https://old.international-pharma.com/wp-content/uploads/2021/06/Nemera-QUADRI-002.jpg https://old.international-pharma.com/abpi-forms-new-patient-advisory-council/ 2023-10-19T22:51:58+00:00 https://old.international-pharma.com/us-approves-pradaxa-as-oral-blood-thinning-med-for-children/ 2023-10-19T22:51:57+00:00 https://old.international-pharma.com/takeda-and-tech-start-up-partner-on-biopharmaceuticals/ 2023-10-19T22:51:57+00:00 https://old.international-pharma.com/eu-green-lights-az-msds-rare-disease-therapy-koselugo/ 2023-10-19T22:51:56+00:00 https://old.international-pharma.com/bauschstrobel/ 2023-10-19T22:51:55+00:00 https://old.international-pharma.com/wp-content/uploads/2021/06/BS_Buildings-scaled-1.jpg https://old.international-pharma.com/wp-content/uploads/2021/06/BS_vial-transport.jpg https://old.international-pharma.com/wp-content/uploads/2021/06/BS_vial-filling.jpg https://old.international-pharma.com/wp-content/uploads/2021/06/BS_syringes-scaled-1.jpg https://old.international-pharma.com/wp-content/uploads/2021/06/BS_production-line-scaled-1.jpg https://old.international-pharma.com/wp-content/uploads/2021/06/BS_CombiSys.jpg https://old.international-pharma.com/novartis-radioligand-therapy-granted-us-breakthrough-therapy-designation/ 2023-10-19T22:51:55+00:00 https://old.international-pharma.com/complex-system-for-blending-sieving-granulation-and-tableting/ 2023-10-19T22:51:51+00:00 https://old.international-pharma.com/wp-content/uploads/2021/06/LB-Bohle.jpg https://old.international-pharma.com/drug-delivery-innovation-across-europe-improves-for-third-consecutive-year-ahead-of-pharmapack-europe/ 2023-10-19T22:51:50+00:00 https://old.international-pharma.com/cphi-report-predicts-supercharged-partnering-in-usa-pharma-sector-over-the-next-18-months/ 2023-10-19T22:51:49+00:00 https://old.international-pharma.com/abpi-launches-updated-code-of-practice/ 2023-10-19T22:51:48+00:00 https://old.international-pharma.com/owen-mumford-achieves-b-corp-certification/ 2023-10-19T22:51:48+00:00 https://old.international-pharma.com/wp-content/uploads/2021/06/Owen-Mumford-Jarl-Severn-scaled-1.jpg https://old.international-pharma.com/biomarin-resubmits-haemophilia-a-gene-therapy-to-the-ema/ 2023-10-19T22:51:47+00:00 https://old.international-pharma.com/the-role-of-hostile-vehicle-mitigation-in-a-protective-security-strategy/ 2023-10-19T22:51:46+00:00 https://old.international-pharma.com/pharma-airports-a-key-to-global-success/ 2023-10-19T22:51:46+00:00 https://old.international-pharma.com/trust-but-verify-importance-of-packaging-compendial-testing-to-secure-the-parenteral-drug-supply-chain/ 2023-10-19T22:51:45+00:00 https://old.international-pharma.com/lessons-learned-from-the-covid-19-vaccine-cold-chain-control-tower/ 2023-10-19T22:51:45+00:00 https://old.international-pharma.com/covid-vaccination-serialisation-the-journey-so-far/ 2023-10-19T22:51:41+00:00 https://old.international-pharma.com/tackling-supplier-management-challenges-to-build-a-more-agile-and-resilient-supply-chain/ 2023-10-19T22:51:40+00:00 https://old.international-pharma.com/eu-falsified-medicines-directive-fmd-a-technical-implementation-success/ 2023-10-19T22:51:39+00:00 https://old.international-pharma.com/thinking-inside-the-box/ 2023-10-19T22:51:39+00:00 https://old.international-pharma.com/fake-medications-suggestions-and-approaches-to-help-ensure-that-patients-and-their-family-members-are-not-left-worrying/ 2023-10-19T22:51:38+00:00 https://old.international-pharma.com/how-the-rise-of-biologics-is-spurring-a-packaging-revolution/ 2023-10-19T22:51:37+00:00 https://old.international-pharma.com/serialisation-headache-or-opportunity/ 2023-10-19T22:51:37+00:00 https://old.international-pharma.com/extrusion-moulding-coating-process-advantages-for-continuous-manufacturing-of-oral-solid-dosage-forms/ 2023-10-19T22:51:36+00:00 https://old.international-pharma.com/pharmaceutical-trends-water-activity-measurement/ 2023-10-19T22:51:35+00:00 https://old.international-pharma.com/dwell-time-and-its-influence-on-tablet-production/ 2023-10-19T22:51:35+00:00 https://old.international-pharma.com/medical-monitors-conundrum-making-sense-of-site-central-discordance-in-radiology-assessment/ 2023-10-19T22:51:31+00:00 https://old.international-pharma.com/choosing-the-right-device-to-deliver-your-new-therapy-four-simple-steps/ 2023-10-19T22:51:30+00:00 https://old.international-pharma.com/accelerating-pharma-research-with-sensitive-spatial-analysis-of-challenging-molecules/ 2023-10-19T22:51:29+00:00 https://old.international-pharma.com/how-endotoxin-contamination-can-affect-gene-and-cell-therapies/ 2023-10-19T22:51:29+00:00 https://old.international-pharma.com/compartmentalised-microfluidic-devices-for-drug-discovery-in-the-neurosciences/ 2023-10-19T22:51:28+00:00 https://old.international-pharma.com/time-to-put-the-spotlight-on-the-substance-of-your-drugs-through-solid-form-development/ 2023-10-19T22:51:28+00:00 https://old.international-pharma.com/multifactorial-disease-models-their-role-in-de-risking-topical-formulation-development/ 2023-10-19T22:51:27+00:00 https://old.international-pharma.com/digital-technology-for-building-resilient-healthcare-systems-in-thailand-and-southeast-asia/ 2023-10-19T22:51:26+00:00 https://old.international-pharma.com/how-technology-can-help-build-a-fairer-healthier-world/ 2023-10-19T22:51:25+00:00 https://old.international-pharma.com/the-eu-medical-devices-regulation-and-its-market-impact-under-the-spotlight/ 2023-10-19T22:51:25+00:00 https://old.international-pharma.com/a-world-leader-in-naturally-derived-products-discusses-commercial-success-and-new-innovations/ 2023-10-19T22:51:21+00:00 https://old.international-pharma.com/oxford-researchers-launch-hiv-vaccine-trial/ 2023-10-19T22:51:20+00:00 https://old.international-pharma.com/renaissance-sri-lanka-launches-the-kumbuk-online-networking-platform/ 2023-10-19T22:51:20+00:00 https://old.international-pharma.com/govt-announces-2-45m-funding-to-improve-maternity-safety/ 2023-10-19T22:51:19+00:00 https://old.international-pharma.com/govt-sets-out-ten-year-strategy-for-the-uks-life-sciences-sector/ 2023-10-19T22:51:18+00:00 https://old.international-pharma.com/jardiance-becomes-first-sglt2-inhibitor-to-show-benefit-in-hfpef/ 2023-10-19T22:51:18+00:00 https://old.international-pharma.com/acg-appoints-v-ashok-as-group-chief-financial-officer/ 2023-10-19T22:51:17+00:00 https://old.international-pharma.com/nemera-and-biomm-sign-partnership-agreement-to-commercialize-reusable-insulin-pen-in-brazil/ 2023-10-19T22:51:16+00:00 https://old.international-pharma.com/cambridge-scientists-identify-200-approved-drugs-predicted-to-work-against-covid-19/ 2023-10-19T22:51:16+00:00 https://old.international-pharma.com/avantor-introduces-j-t-baker-high-quality-robotic-tips-for-laboratory-robotic-and-liquid-handling-systems/ 2023-10-19T22:51:15+00:00 https://old.international-pharma.com/aetion-and-cegedim-expand-real-world-data-partnership/ 2023-10-19T22:50:58+00:00 https://old.international-pharma.com/quidel-gains-ce-mark-for-combined-covid-19-flu-and-rsv-diagnostic-test/ 2023-10-19T22:50:58+00:00 https://old.international-pharma.com/new-hope-for-long-covid-blood-tests-after-antibody-discovery/ 2023-10-19T22:50:57+00:00 https://old.international-pharma.com/biontech-to-develop-mrna-based-malaria-vaccine-following-covid-19-success/ 2023-10-19T22:50:56+00:00 https://old.international-pharma.com/tecentriq-kesimpta-lead-latest-smc-decisions/ 2023-10-19T22:50:56+00:00 https://old.international-pharma.com/nice-publishes-new-draft-guideline-covering-rehabilitation-after-traumatic-injury/ 2023-10-19T22:50:55+00:00 https://old.international-pharma.com/eu-backs-approval-of-modernas-covid-19-vaccine-in-12-17-year-olds/ 2023-10-19T22:50:51+00:00 https://old.international-pharma.com/researchers-find-extending-the-time-between-pfizer-doses-boosts-antibodies/ 2023-10-19T22:50:50+00:00 https://old.international-pharma.com/biontech-to-develop-a-mrna-based-malaria-vaccine/ 2023-10-19T22:50:49+00:00 https://old.international-pharma.com/four-drug-combo-therapy-shows-benefit-for-newly-diagnosed-myeloma-patients/ 2023-10-19T22:50:49+00:00 https://old.international-pharma.com/syneos-health-and-aetion-partner-to-offer-real-world-evidence-solutions/ 2023-10-19T22:50:48+00:00 https://old.international-pharma.com/santen-and-sydnexis-partner-on-childhood-myopia-treatment-syd-101/ 2023-10-19T22:50:47+00:00 https://old.international-pharma.com/cphi-partners-with-sgs-for-company-verification-service/ 2023-10-19T22:50:47+00:00 https://old.international-pharma.com/uk-approval-for-epidyolex-to-treat-seizures-from-tuberous-sclerosis/ 2023-10-19T22:50:46+00:00 https://old.international-pharma.com/smc-approves-bavencio-for-bladder-cancer/ 2023-10-19T22:50:45+00:00 https://old.international-pharma.com/enhertu-improves-progression-free-survival-in-breast-cancer-trial/ 2023-10-19T22:50:41+00:00 https://old.international-pharma.com/takeda-takes-the-lead-on-finchs-ulcerative-colitis-candidate-fin-524/ 2023-10-19T22:50:40+00:00 https://old.international-pharma.com/azs-forxiga-gains-ec-mhra-approvals-for-chronic-kidney-disease/ 2023-10-19T22:50:40+00:00 https://old.international-pharma.com/us-rejects-az-and-fibrogens-anaemia-drug-roxadustat/ 2023-10-19T22:50:39+00:00 https://old.international-pharma.com/fda-approves-keytruda-plus-lenvima-for-advanced-kidney-cancer/ 2023-10-19T22:50:38+00:00 https://old.international-pharma.com/further-clinical-trial-planned-for-valnevas-covid-19-vaccine-candidate/ 2023-10-19T22:50:38+00:00 https://old.international-pharma.com/modernas-covid-19-vaccine-maintains-antibodies-to-six-months-study-shows/ 2023-10-19T22:50:37+00:00 https://old.international-pharma.com/fda-approves-first-covid-19-vaccine/ 2023-10-19T22:50:36+00:00 https://old.international-pharma.com/fda-approval-for-xywav-for-idiopathic-hypersomnia-in-adults/ 2023-10-19T22:50:36+00:00 https://old.international-pharma.com/new-data-at-esc-congress-2021-showcase-astrazenecas-leading-cardiovascular-renal-and-metabolic-portfolio/ 2023-10-19T22:50:35+00:00 https://old.international-pharma.com/novartis-kymriah-fails-to-hit-primary-survival-endpoint-in-late-stage-trial/ 2023-10-19T22:50:31+00:00 https://old.international-pharma.com/kuvan-approved-for-pregnant-women-with-pku-in-uk/ 2023-10-19T22:50:30+00:00 https://old.international-pharma.com/merck-partners-with-start-up-for-neurostimulator-development/ 2023-10-19T22:50:30+00:00 https://old.international-pharma.com/eu-nod-for-bimzelx-for-moderate-to-severe-plaque-psoriasis/ 2023-10-19T22:50:29+00:00 https://old.international-pharma.com/dupixent-trial-meets-endpoints-for-childhood-eczema/ 2023-10-19T22:50:28+00:00 https://old.international-pharma.com/sk-bioscience-and-gsk-start-phase-3-trial-of-adjuvanted-covid-19-vaccine-candidate/ 2023-10-19T22:50:28+00:00 https://old.international-pharma.com/roche-withdraws-us-approval-for-tecentriq-in-mtnbc/ 2023-10-19T22:50:27+00:00 https://old.international-pharma.com/icr-cancer-drug-nxp800-to-enter-phase-i-trials/ 2023-10-19T22:50:26+00:00 https://old.international-pharma.com/phase-iii-data-for-jardiance-shows-improvement-in-hfpef-patients/ 2023-10-19T22:50:26+00:00 https://old.international-pharma.com/ema-fast-tracks-marinus-pharmas-rare-epilepsy-treatment/ 2023-10-19T22:50:25+00:00 https://old.international-pharma.com/nice-recommends-novartis-secukinumab-for-children-with-moderate-to-severe-psoriasis/ 2023-10-19T22:50:21+00:00 https://old.international-pharma.com/new-tezepelumab-data-shows-improvements-for-severe-asthma-subgroup/ 2023-10-19T22:50:20+00:00 https://old.international-pharma.com/jcvi-does-not-recommend-covid-19-vaccination-for-all-12-to-15-year-olds/ 2023-10-19T22:50:20+00:00 https://old.international-pharma.com/cma-launches-formal-investigation-into-covid-19-pcr-test-firm/ 2023-10-19T22:50:19+00:00 https://old.international-pharma.com/ilc-therapeutics-raises-3-5m-to-advance-lead-interferon-drug-candidate/ 2023-10-19T22:50:18+00:00 https://old.international-pharma.com/metformin-preparation-station-with-potential-to-become-a-bestseller-combination-of-lump-breaker-and-bts-conical-mill/ 2023-10-19T22:50:17+00:00 https://old.international-pharma.com/wp-content/uploads/2021/09/Lb-Bohle-1.jpg https://old.international-pharma.com/wp-content/uploads/2021/09/Lb-Bohle-2-scaled.jpg https://old.international-pharma.com/govt-injects-5-4bn-to-support-nhs-englands-covid-19-response/ 2023-10-19T22:50:17+00:00 https://old.international-pharma.com/minimising-vaccine-wastage-with-advanced-refrigerator-and-freezer-technologies/ 2023-10-19T22:50:16+00:00 https://old.international-pharma.com/how-to-approach-an-nlg-solution-in-the-pharmaceutical-industry/ 2023-10-19T22:50:16+00:00 https://old.international-pharma.com/addressing-value-based-care-needs-with-parenteral-packaging/ 2023-10-19T22:50:15+00:00 https://old.international-pharma.com/innovative-user-friendly-child-resistant-packaging-solutions/ 2023-10-19T22:50:11+00:00 https://old.international-pharma.com/smart-packaging-for-smart-devices-designing-a-good-user-experience/ 2023-10-19T22:50:10+00:00 https://old.international-pharma.com/new-dpi-data-insights-shaping-future-of-global-healthcare-needs/ 2023-10-19T22:50:09+00:00 https://old.international-pharma.com/aseptic-processing-and-cleanroom-technology/ 2023-10-19T22:50:09+00:00 https://old.international-pharma.com/small-scale-batch-production-for-clinical-gamma-scintigraphy-studies-of-pharmaceuticals/ 2023-10-19T22:50:08+00:00 https://old.international-pharma.com/formulation-and-process-considerations-for-optimising-spray-dried-solid-dispersions/ 2023-10-19T22:50:07+00:00 https://old.international-pharma.com/from-rd-to-production-how-the-bioreactor-choice-can-streamline-biologics-scale-up/ 2023-10-19T22:50:07+00:00 https://old.international-pharma.com/how-to-future-proof-the-manufacture-of-sterile-drug-products/ 2023-10-19T22:50:06+00:00 https://old.international-pharma.com/building-common-ground-for-collective-intelligence/ 2023-10-19T22:50:05+00:00 https://old.international-pharma.com/how-technology-is-making-an-impact-in-improving-managed-access-programs/ 2023-10-19T22:50:03+00:00 https://old.international-pharma.com/beyond-the-pill-why-reliable-electronics-is-key-to-healthcare/ 2023-10-19T22:49:59+00:00 https://old.international-pharma.com/the-case-for-a-distributable-cdx-model/ 2023-10-19T22:49:58+00:00 https://old.international-pharma.com/current-trends-in-formulation-development-and-implications-for-drug-delivery-devices/ 2023-10-19T22:49:57+00:00 https://old.international-pharma.com/managing-the-inherent-complexity-and-risk-of-precision-medicine-clinical-supply-chains/ 2023-10-19T22:49:57+00:00 https://old.international-pharma.com/improving-productivity-in-discovery-research-workflow-management/ 2023-10-19T22:49:56+00:00 https://old.international-pharma.com/smart-inhalers-a-digital-step-towards-patient-centricity/ 2023-10-19T22:49:55+00:00 https://old.international-pharma.com/methods-to-reduce-the-anxiety-of-mental-disorder-medication/ 2023-10-19T22:49:55+00:00 https://old.international-pharma.com/changing-the-face-of-infection-prevention/ 2023-10-19T22:49:54+00:00 https://old.international-pharma.com/assessing-the-environmental-trade-offs-of-medical-device-technology/ 2023-10-19T22:49:53+00:00 https://old.international-pharma.com/biotech-in-china-maximising-the-global-opportunity/ 2023-10-19T22:49:53+00:00 https://old.international-pharma.com/at-the-forefront-of-innovative-therapeutic-excellence-since-2006/ 2023-10-19T22:49:48+00:00 https://old.international-pharma.com/managing-regulatory-requirements-as-the-medtech-sectors-sees-unprecedented-growth/ 2023-10-19T22:49:48+00:00 https://old.international-pharma.com/nhs-launches-worlds-largest-trial-of-cancer-blood-test/ 2023-10-19T22:49:47+00:00 https://old.international-pharma.com/adacores-qgen-automated-code-generator-helps-develop-new-artificial-lung-equipment-to-treat-covid-patients-in-only-six-months/ 2023-10-19T22:49:46+00:00 https://old.international-pharma.com/uk-government-terminates-covid-19-vaccine-agreement-with-valneva/ 2023-10-19T22:49:46+00:00 https://old.international-pharma.com/after-regulatory-nods-johnson-johnson-says-latest-ebola-vaccine-data-could-support-prophylactic-use/ 2023-10-19T22:49:45+00:00 https://old.international-pharma.com/sanofi-regenerons-libtayo-hits-the-mark-in-first-line-nsclc/ 2023-10-19T22:49:44+00:00 https://old.international-pharma.com/pharmapack-report-2021-us-leads-on-drug-device-innovation-but-trails-europe-on-sustainability/ 2023-10-19T22:49:44+00:00 https://old.international-pharma.com/promising-early-results-for-new-ovarian-cancer-drug-combo/ 2023-10-19T22:49:43+00:00 https://old.international-pharma.com/positive-topline-results-for-pfizer-biontech-jab-in-five-to-11-year-olds/ 2023-10-19T22:49:42+00:00 https://old.international-pharma.com/miratis-adagrasib-scores-encouraging-results-in-kras-mutated-lung-cancer/ 2023-10-19T22:49:38+00:00 https://old.international-pharma.com/new-report-sheds-light-on-medicine-shortages-in-northern-ireland-following-brexit/ 2023-10-19T22:49:37+00:00 https://old.international-pharma.com/fda-approves-exelixis-cabometyx-for-differentiated-thyroid-cancer/ 2023-10-19T22:49:37+00:00 https://old.international-pharma.com/positive-phase-iii-results-for-lynparza-plus-abiraterone-in-metastatic-prostate-cancer/ 2023-10-19T22:49:36+00:00 https://old.international-pharma.com/uk-trial-to-evaluate-existing-drugs-for-secondary-breast-cancer/ 2023-10-19T22:49:35+00:00 https://old.international-pharma.com/astrazeneca-invests-in-imperial-college-spin-off-vaxequity/ 2023-10-19T22:49:35+00:00 https://old.international-pharma.com/cancer-care-backlog-in-england-could-take-over-a-decade-to-clear-report-finds/ 2023-10-19T22:49:34+00:00 https://old.international-pharma.com/merck-announces-its-antiviral-covid-19-pill-halves-hospitalisations-and-deaths/ 2023-10-19T22:49:33+00:00 https://old.international-pharma.com/nice-recommends-first-sickle-cell-disease-treatment-in-two-decades/ 2023-10-19T22:49:33+00:00 https://old.international-pharma.com/largest-covid-19-pcr-provider-announces-expansion-of-cube-labs/ 2023-10-19T22:49:32+00:00 https://old.international-pharma.com/chmp-positive-option-for-pfizer-biontech-covid-19-vaccine-in-the-eu/ 2023-10-19T22:49:28+00:00 https://old.international-pharma.com/aipharma-forms-alliance-with-appili-therapeutics/ 2023-10-19T22:49:27+00:00 https://old.international-pharma.com/ppma-show-2021-celebrates-great-success-as-it-leads-the-way-to-build-back-business/ 2023-10-19T22:49:26+00:00 https://old.international-pharma.com/pharmapack-europe-2021-award-winners-announced/ 2023-10-19T22:49:25+00:00 https://old.international-pharma.com/wp-content/uploads/2021/10/Pharmapack_2020_0040-scaled.jpg https://old.international-pharma.com/pharmapack-report-2021-digital-data-democratization-environmental-factors-user-experience-driving-device-innovation-in-2022/ 2023-10-19T22:49:25+00:00 https://old.international-pharma.com/dotmatics-and-rockstep-partner-on-digitalised-in-vivo-drug-discovery/ 2023-10-19T22:49:24+00:00 https://old.international-pharma.com/chemotherapy-drug-derived-from-fungus-shows-promise/ 2023-10-19T22:49:23+00:00 https://old.international-pharma.com/astrazenecas-long-acting-antibody-combination-treats-and-prevents-covid-19/ 2023-10-19T22:49:23+00:00 https://old.international-pharma.com/gsk-plans-uk-headquarters-for-new-consumer-healthcare-company/ 2023-10-19T22:49:22+00:00 https://old.international-pharma.com/symbioze-the-smart-high-volume-and-sustainable-on-body-injector-platform-developed-by-nemera-wins-the-connected-devices-and-wearables-award-at-pharmapack-2021/ 2023-10-19T22:49:21+00:00 https://old.international-pharma.com/wp-content/uploads/2021/10/Nemera-Pharmapack-Award-winner-SYMBIOZE.png https://old.international-pharma.com/wp-content/uploads/2021/10/Nemera-_Symbioze-scaled.jpg https://old.international-pharma.com/wp-content/uploads/2021/10/Nemera_Symbioze_Patient.jpg https://old.international-pharma.com/wp-content/uploads/2021/10/Nemera-Symbioze-features.jpg https://old.international-pharma.com/b-medical-systems-production-area-extension/ 2023-10-19T22:49:17+00:00 https://old.international-pharma.com/wp-content/uploads/2021/10/Luxembourg-factory-launch-scaled.jpg https://old.international-pharma.com/wp-content/uploads/2015/04/10b.jpg https://old.international-pharma.com/wp-content/uploads/2015/04/9a.jpg https://old.international-pharma.com/wp-content/uploads/2015/04/8a.jpg https://old.international-pharma.com/new-sterile-fill-and-finish-area-for-vials-and-prefilled-syringes-at-aenova/ 2023-10-19T22:49:16+00:00 https://old.international-pharma.com/wp-content/uploads/2021/10/Aenova_New_sterile_area_Latina_2-scaled.jpg https://old.international-pharma.com/nemera-joins-ipac-rs-as-an-associate-member/ 2023-10-19T22:49:16+00:00 https://old.international-pharma.com/wp-content/uploads/2021/10/Nemera.jpg https://old.international-pharma.com/mindmaze-forms-partnership-to-manufacture-brain-repair-platform-for-stroke-patients/ 2023-10-19T22:49:15+00:00 https://old.international-pharma.com/new-asthma-drug-approved-on-nhs-branded-a-wonder-drug/ 2023-10-19T22:49:14+00:00 https://old.international-pharma.com/nice-does-not-recommend-tucatinib-for-advanced-breast-cancer/ 2023-10-19T22:49:13+00:00 https://old.international-pharma.com/short-term-reshoring-the-catalyst-for-longer-term-manufacturing-innovations-by-2030/ 2023-10-19T22:49:13+00:00 https://old.international-pharma.com/uk-covid-19-patients-able-to-take-gp-prescribed-medicine-at-home/ 2023-10-19T22:49:12+00:00 https://old.international-pharma.com/roche-launches-comprehensive-genomic-profiling-kit-to-expand-access-to-personalised-cancer-research/ 2023-10-19T22:49:11+00:00 https://old.international-pharma.com/mhra-licenses-ryeqo-for-symptoms-of-uterine-fibroids/ 2023-10-19T22:49:11+00:00 https://old.international-pharma.com/pfizer-and-biontech-announce-phase-3-trial-data-showing-high-efficacy-of-a-booster-dose-of-their-covid-19-vaccine/ 2023-10-19T22:49:07+00:00 https://old.international-pharma.com/nemera-launches-unispray-its-unidose-system-primarily-for-systemic-acting-drug-administration/ 2023-10-19T22:49:06+00:00 https://old.international-pharma.com/wp-content/uploads/2021/10/Nemera-1_UniSpray.png https://old.international-pharma.com/wp-content/uploads/2021/10/Nemera-2_Unispray_Patient.jpg https://old.international-pharma.com/wp-content/uploads/2021/10/Nemera-3_UniSpray_label-002.jpg https://old.international-pharma.com/wp-content/uploads/2021/10/Nemera-4_Unispray_Patient_2.jpg https://old.international-pharma.com/first-authorisation-for-novavax-covid-19-jab-announced/ 2023-10-19T22:49:05+00:00 https://old.international-pharma.com/az-to-transfer-certain-drug-rights-to-covis-pharma-for-270m/ 2023-10-19T22:49:05+00:00 https://old.international-pharma.com/global-vaccine-trade-surpasses-42-billion/ 2023-10-19T22:49:04+00:00 https://old.international-pharma.com/uk-government-to-cut-cost-of-repeatable-hrt-prescriptions/ 2023-10-19T22:49:03+00:00 https://old.international-pharma.com/takeda-acquires-gammadelta-therapeutics/ 2023-10-19T22:49:03+00:00 https://old.international-pharma.com/aragen-expects-to-ride-wave-of-us-biotech-growth-in-2022-influx-of-discovery-capital-is-surging-demand-for-cdmo-services/ 2023-10-19T22:49:02+00:00 https://old.international-pharma.com/aenova-increases-production-capacity-for-solid-dosage-forms-at-tittmoning-site-to-up-to-10-billion-tablets-per-year/ 2023-10-19T22:49:01+00:00 https://old.international-pharma.com/wp-content/uploads/2021/11/Aenova_Site-Extension_Tittmoning_external-view-zoom.jpg https://old.international-pharma.com/az-announces-us-fast-track-designation-for-il-5-inhibitor-fasenra/ 2023-10-19T22:49:00+00:00 https://old.international-pharma.com/positive-results-for-gsks-anaemia-drug-daprodustat/ 2023-10-19T22:48:56+00:00